Periodontitis is a chronic infectious disease driven by dysbiosis, an imbalance between commensal bacteria and the host organism. Periodontitis is a leading cause of tooth loss in adults and occurs in about 50% of the US population. In addition to the clinical challenges associated with treating periodontitis, the progression and chronic nature of this disease seriously affect human health. Emerging evidence suggests that periodontitis is associated with mechanisms beyond bacteria-induced protein and tissue degradation. Here, we hypothesize that bacteria are able to induce epigenetic modifications in oral epithelial cells mediated by histone modifications. In this study, we found that dysbiosis in vivo led to epigenetic modifications, including acetylation of histones and downregulation of DNA methyltransferase 1. In addition, in vitro exposure of oral epithelial cells to lipopolysaccharides resulted in histone modifications, activation of transcriptional coactivators, such as p300/CBP, and accumulation of nuclear factor–κB (NF-κB). Given that oral epithelial cells are the first line of defense for the periodontium against bacteria, we also evaluated whether activation of pathogen recognition receptors induced histone modifications. We found that activation of the Toll-like receptors 1, 2, and 4 and the nucleotide-binding oligomerization domain protein 1 induced histone acetylation in oral epithelial cells. Our findings corroborate the emerging concept that epigenetic modifications play a role in the development of periodontitis.
AbeTHajishengallisG. 2013. Optimization of the ligature-induced periodontitis model in mice. J Immunol Methods. 394(1–2):49–54.
2.
Abu-AmerY. 2013. NF-kappaB signaling and bone resorption. Osteoporosis Int. 24(9):2377–2386.
3.
BarnesPJ. 2009. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Proc Am Thoracic Soc. 6(8):693–696.
4.
BarrosSPOffenbacherS. 2014. Modifiable risk factors in periodontal disease: epigenetic regulation of gene expression in the inflammatory response. Periodontology2000. 64(1):95–110.
5.
BaumgartDCCardingSR. 2007. Inflammatory bowel disease: cause and immunobiology. Lancet. 369(9573):1627–1640.
BrownellJEAllisCD. 1996. Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr Opin Genet Dev. 6(2):176–184.
8.
CantleyMDBartoldPMMarinoVFairlieDPLeGTLuckeAJHaynesDR. 2011. Histone deacetylase inhibitors and periodontal bone loss. J Periodontal Res. 46(6):697–703.
9.
CasadesusJLowD. 2006. Epigenetic gene regulation in the bacterial world. Microbiol Mol Biol Rev. 70(3):830–856.
10.
DarveauRPHancockRE. 1983. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol. 155(2):831–838.
11.
de Camargo PereiraGGuimaraesGNPlanelloACSantamariaMPde SouzaAPLineSRMarquesMR. 2013. Porphyromonas gingivalis LPS stimulation downregulates DNMT1, DNMT3a, and JMJD3 gene expression levels in human HaCaT keratinocytes. Clin Oral Invest. 17(4):1279–1285.
12.
De PalmaGNadalIMedinaMDonatERibes-KoninckxCCalabuigMSanzY. 2010. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. 10:63.
13.
DemmerRTDesvarieuxM. 2006. Periodontal infections and cardiovascular disease: the heart of the matter. J Am Dental Assoc. 137(Suppl):14S–20S; quiz 38S.
EllisTNKuehnMJ. 2010. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev. 74(1):81–94.
18.
FunderburgNTJadlowskyJKLedermanMMFengZWeinbergASiegSF. 2011. The Toll-like receptor 1/2 agonists Pam(3) CSK(4) and human beta-defensin-3 differentially induce interleukin-10 and nuclear factor–kappaB signalling patterns in human monocytes. Immunology. 134(2):151–160.
19.
GravesDTKangJAndriankajaOWadaKRossaCJr. 2012. Animal models to study host-bacteria interactions involved in periodontitis. Frontiers Oral Biol. 15:117–132.
20.
HongJLiDWandsJSouzaRCaoW. 2013. Role of NADPH oxidase NOX5-S, NF-kappaB, and DNMT1 in acid-induced p16 hypermethylation in Barrett’s cells. Am J Physiol Cell Physiol. 305(10):C1069–C1079.
21.
HugosonANorderydO. 2008. Has the prevalence of periodontitis changed during the last 30 years?J Clin Periodontol. 35(8 Suppl):338–345.
22.
ImaiKInoueHTamuraMCuenoMEInoueHTakeichiOKusamaKSaitoIOchiaiK. 2012. The periodontal pathogen Porphyromonas gingivalis induces the Epstein-Barr virus lytic switch transactivator ZEBRA by histone modification. Biochimie. 94(3):839–846.
23.
ImaiKOchiaiKOkamotoT. 2009. Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. J Immunol. 182(6):3688–3695.
24.
InoharaNOguraYChenFFMutoANuñezG. 2001. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem. 276(4):2551–2554.
25.
JenuweinTAllisCD. 2001. Translating the histone code. Science. 293(5532):1074–1080.
26.
JiaoYDarziYTawaratsumidaKMarchesanJTHasegawaMMoonHChenGYNuñezGGiannobileWVRaesJ. 2013. Induction of bone loss by pathobiont-mediated Nod1 signaling in the oral cavity. Cell Host Microbe. 13(5):595–601.
27.
JiaoYHasegawaMInoharaN. 2014. The role of oral pathobionts in dysbiosis during periodontitis development. J Dental Res. 93(6):539–546.
28.
KimHJHawkeNBaldwinAS. 2006. NF-kappaB and IKK as therapeutic targets in cancer. Cell Death Different. 13(5):738–747.
29.
KimYKimKParkDLeeELeeHLeeYSChoeJKimYMJeoungD. 2013. DNA methyl transferase I acts as a negative regulator of allergic skin inflammation. Mol Immunol. 53(1–2):1–14.
30.
KornmanKS. 2008. Mapping the pathogenesis of periodontitis: a new look. J Periodontol. 79(8 Suppl):1560–1568.
31.
LarssonLCastilhoRMGiannobileWV. 2015. Epigenetics and its role in periodontal diseases: a state-of-the-art review. J Periodontol. 86(4):556–568.
32.
LarssonLThorbert-MrosSRymoLBerglundhT. 2012. Influence of epigenetic modifications of the interleukin-10 promoter on IL10 gene expression. Eur J Oral Sci. 120(1):14–20.
33.
LeeEYChoiDSKimKPGhoYS. 2008. Proteomics in gram-negative bacterial outer membrane vesicles. Mass Spectrometry Rev. 27(6):535–555.
34.
LiuRDestaTRaptisMDarveauRPGravesDT. 2008. P. gingivalis and E. coli lipopolysaccharides exhibit different systemic but similar local induction of inflammatory markers. J Periodontol. 79(7):1241–1247.
35.
LiuSLiuZXieZPangJYuJLehmannEHuynhLVukosavljevicTTakekiMKlisovicRB. 2008. Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia. Blood. 111(4):2364–2373.
36.
MahanondaRPichyangkulS. 2007. Toll-like receptors and their role in periodontal health and disease. Periodontology2000. 43:41–55.
37.
MarchesanJTMorelliTLundySKJiaoYLimSInoharaNNunezGFoxDAGiannobileWV. 2012. Divergence of the systemic immune response following oral infection with distinct strains of Porphyromonas gingivalis. Mol Oral Microbiol. 27(6):483–495.
38.
MasumotoJYangKVaramballySHasegawaMTomlinsSAQiuSFujimotoYKawasakiAFosterSJHorieY. 2006. Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J Exp Med. 203(1):203–213.
39.
Mata-HaroVCekicCMartinMChiltonPMCasellaCRMitchellTC. 2007. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science. 316(5831):1628–1632.
40.
MoalliFParoniMVeliz RodriguezTRivaFPolentaruttiNBottazziBValentinoSManteroSNebuloniMMantovaniA. 2011. The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa. J Immunol. 186(9):5425–5434.
41.
OpalSM. 2007. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol. 297(5):365–377.
42.
Padial-MolinaMVolkSLRodriguezJCMarchesanJTGalindo-MorenoPRiosHF. 2013. Tumor necrosis factor–alpha and Porphyromonas gingivalis lipopolysaccharides decrease periostin in human periodontal ligament fibroblasts. J Periodontol. 84(5):694–703.
43.
RobertsonKDWolffeAP. 2000. DNA methylation in health and disease. Nat Rev Genet. 1(1):11–19.
44.
Sánchez-PernauteOOspeltCNeidhartMGayS. 2008. Epigenetic clues to rheumatoid arthritis. J Autoimmun. 30(1–2):12–20.
45.
SignatBRoquesCPouletPDuffautD. 2011. Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol. 13(2):25–36.
46.
SunYShuRLiCLZhangMZ. 2010. Gram-negative periodontal bacteria induce the activation of Toll-like receptors 2 and 4, and cytokine production in human periodontal ligament cells. J Periodontol. 81(10):1488–1496.
47.
YinLChungWO. 2011. Epigenetic regulation of human beta-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria. Mucosal Immunol. 4(4):409–419.
48.
ZhangSBarrosSPMorettiAJYuNZhouJPreisserJSNiculescuMDOffenbacherS. 2013. Epigenetic regulation of TNFA expression in periodontal disease. J Periodontol. 84(11):1606–1616.
49.
ZhangSBarrosSPNiculescuMDMorettiAJPreisserJSOffenbacherS. 2010. Alteration of PTGS2 promoter methylation in chronic periodontitis. J Dental Res. 89(2):133–137.
50.
ZhongHMayMJJimiEGhoshS. 2002. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell. 9(3):625–636.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
